# A Study of Stapokibatrt in Children Subjects With Atopic Dermatitis

> **NCT07106372** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Keymed Biosciences Co.Ltd** · enrollment: 240 (estimated)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **BIOLOGICAL:** Stapokibatrt

## Key facts

- **NCT ID:** NCT07106372
- **Lead sponsor:** Keymed Biosciences Co.Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09
- **Primary completion:** 2027-02
- **Final completion:** 2027-06
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2025-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07106372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07106372, "A Study of Stapokibatrt in Children Subjects With Atopic Dermatitis". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT07106372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*